Medication info

Hanol Amine Plus Injection

Prescription medicationInjections
Ingredient · strength
L-Isoleucine›0.91g / 100mLL-Leucine›1.29g / 100mLL-Lysine Acetate›1g / 100mLL-Methionine›0.44g / 100mLL-Phenylalanine›0.7g / 100mLL-Threonine›0.75g / 100mLL-Tryptophan›0.13g / 100mLL-Valine›1.4g / 100mLL-Alanine›0.71g / 100mLL-Arginine›0.9g / 100mLL-Histidine›0.5g / 100mLL-Proline›0.5g / 100mLL-Serine›0.17g / 100mLGlycine›0.7g / 100mLL-Cysteine›35mg / 100mLL-Glutamic Acid›50mg / 100mLL-Tyrosine›40mg / 100mLL-Aspartic Acid›0.1g / 100mL
Manufacturer / importer
Hanol BioPharma Co., Ltd.
Appearance
A colorless to pale yellow transparent liquid contained in a polypropylene aqueous injection vial.
Packaging
200 mL/bag, 250 mL/bag
Approval status
Active

MFDS item code 199500227 · Notified 1995.07.07

Summary

Main use
Improvement of nutritional status through amino acid supplementation (e.g., in malnutrition and before or after surgery)
Who uses it
Adults · Children
Adult dosage
○Peripheral venous administration Generally, administer 200~400 mL per dose by intravenous infusion. Rate of administration: As a guide, administer 200 mL over approximately 120 minutes (approximately 25 drops per minute). For optimal utilization in the body, approximately 10 g of total amino acids over 60 minutes is desirable; infuse slowly in elderly patients and patients with severe illness. ○Central venous administration Generally, continuously infuse 400~800 mL per day into a central vein in adults using a high-calorie intravenous infusion regimen. For efficient utilization of amino acids in the body, concurrent administration with a sugar-containing intravenous solution is desirable. Adjust the dose as appropriate according to age, symptoms, and body weight.
Children's dosage
Infuse slowly in children.

Ingredients

Manufacturer
Hanol BioPharma Co., Ltd.

Efficacy & effects

Improvement of nutritional status through amino acid supplementation (e.g., in malnutrition and before or after surgery)

  • Hypoproteinemia
  • malnutrition
View approved original text

This medication can improve the nutritional status of patients and assist in the recovery of bodily functions through the supply of amino acids during hypoproteinemia, malnutrition, and the periods surrounding surgery. Appropriate amino acid supply in such situations promotes protein synthesis in the body and contributes to immune enhancement. Therefore, this medication is used for the supplementation in cases of hypoproteinemia, malnutrition, and nutritional support around surgery.

Dosage and Administration

Adult dosage

○Peripheral venous administration Generally, administer 200~400 mL per dose by intravenous infusion. Rate of administration: As a guide, administer 200 mL over approximately 120 minutes (approximately 25 drops per minute). For optimal utilization in the body, approximately 10 g of total amino acids over 60 minutes is desirable; infuse slowly in elderly patients and patients with severe illness. ○Central venous administration Generally, continuously infuse 400~800 mL per day into a central vein in adults using a high-calorie intravenous infusion regimen. For efficient utilization of amino acids in the body, concurrent administration with a sugar-containing intravenous solution is desirable. Adjust the dose as appropriate according to age, symptoms, and body weight.

Children's dosage

Infuse slowly in children.

Precautions

This medication must be used strictly under the guidance of a physician. It should not be used in patients with hepatic coma or those at risk of hepatic coma. It should also not be administered to patients with severe renal dysfunction or elevated blood nitrogen levels. Patients with issues in nitrogen metabolism should not be given this medication. Patients with severe heart failure or pulmonary edema should also avoid this medication. It should not be administered to patients with very low or absent urine output. If sodium and chloride ions are included, it should not be given to patients with elevated sodium and chloride levels. Patients with a history of myocardial infarction or current myocardial infarction should also refrain from using this medication. Caution is warranted when administering to patients with severe acidosis or congestive heart failure. If sodium ions are included, caution should be exercised in patients with edema due to sodium retention. If potassium ions are contained in amounts above 5 mmol/L, the medication should be administered with caution to patients with hyperkalemia or potassium retention. Patients with liver or kidney impairments also require careful monitoring. Sodium bisulfite included in this medication may cause allergic reactions, particularly in asthma patients, where symptoms can occur more frequently. If hypersensitivity reactions such as rashes occur during the use of this medication, administration should be immediately stopped. Occasionally, gastrointestinal symptoms such as nausea or vomiting may occur. Cardiac-related symptoms may include chest discomfort, palpitations, rapid pulse, and elevated blood pressure. Rapid administration in large volumes may cause acidosis, hence caution is advised. Serious side effects may include chills, fever, headache, dyspnea, and shock. Metabolic complications can include acidosis, hypophosphatemia, alkalosis, hyperglycemia, diabetes, dehydration, etc. Patients with reduced liver or kidney function may experience elevated blood BUN levels. Patients with liver failure are at risk for serum amino acid imbalance, metabolic alkalosis, and coma, necessitating caution. During large-volume administration, electrolyte balance must be carefully monitored, especially when used with electrolyte-containing solutions. In cases of overdose, metabolic alkalosis can occur due to the acetate ions present, and care should be taken. Careful administration is required to prevent fluid overload in patients with a history of kidney disease, lung disease, or heart disease. Diabetes patients should frequently monitor blood sugar levels during administration. When used concurrently with tetracycline antibiotics, the protein-sparing effect may decrease, so caution is advised during co-administration. Safety has not been established in pregnant women, so it should only be used when the therapeutic benefit outweighs the risks. In children, concentrations should be kept low due to immature liver function, and blood ammonia levels should be regularly monitored. Elderly patients require careful dosage adjustments due to decreased bodily functions, and slow administration rates should be followed. This medication contains electrolytes, so caution regarding electrolyte balance is necessary during large volumes of administration, and intravenous administration should be slow. Rapid infusion may cause chills or vomiting and may increase amino acid loss through the kidneys. At lower temperatures, it is advisable to warm it to body temperature for use. Preparation and management of the solution should be done in a sterile manner, and special attention should be paid to the sterilization of injection equipment. Before administration, ensure the solution is transparent and do not use if it is discolored or leaked. During storage, it should be kept sealed from air and moisture, and the remaining solution should be used within 24 hours after opening. If crystals form, dissolve them at 50-60 degrees and allow it to cool to body temperature before use. Soft bag products do not require venting, while vial products should be vented just prior to use. If discoloration or leakage is present in the liquid, or if there are droplets on the exterior, do not use; also do not use if the rubber stopper protective film is peeled off. Use should be accurate based on the graduation of the container.

Side effects

Rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture ingress. It is advisable to keep it away from direct sunlight, at normal room temperature, neither too hot nor too cold.

Appearance and packaging

Appearance

A colorless to pale yellow transparent liquid contained in a polypropylene aqueous injection vial.

Package unit

200 mL/bag, 250 mL/bag

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.